Multifactorial challenges in cardiometabolic disease management: patient, healthcare system, and environmental barriers

Ade Meidian Ambari

Abstract


Cardiometabolic disease is a complicated issue characterized by various contributing factors. The patients typically have multiple comorbidities with mostly modifiable risk factors. Regarding cardiovascular risk factors, patients' long-term dedication, bad diets, sedentary lifestyles, and psychological problems should be closely monitored. In addition to the patient's internal characteristics, environmental factors such as air pollution have also been linked to cardiovascular-related morbidity and death. Improved public health policy and therapeutic resource fulfillment are crucial to reducing the disease burden and ensuring better patient outcomes. The Government should improve the system and encourage the implementation of guidelines-based cardiovascular disease management.


Keywords


Cardiometabolic; Cardiovascular Disease; Environmental Exposure Health Policy; Risk Factors.

Full Text:

PDF

References


Mensah GA, Habtegiorgis Abate Y, Abbasian M, Abd-Allah F, Abdollahi A, Abdollahi M, et al. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol. 2023;82(25):2350–473.

Cosentino F, Verma S, Ambery P, Treppendahl MB, Van Eickels M, Anker SD, et al. Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table. Eur Heart J [Internet]. 2023;44(39):4141–56. Available from: https://doi.org/10.1093/eurheartj/ehad445

Collaboration TERF. Association of Cardiometabolic Multimorbidity With Mortality. JAMA [Internet]. 2015 Jul 7;314(1):52–60. Available from: https://doi.org/10.1001/jama.2015.7008

Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, et al. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol [Internet]. 2021;5(November 2020):100149. Available from: http://dx.doi.org/10.1016/j.ajpc.2021.100149

Nordfonn OK, Morken IM, Bru LE, Larsen AI, Husebø AML. Burden of treatment in patients with chronic heart failure – A cross-sectional study. Hear Lung [Internet]. 2021;50(3):369–74. Available from: https://doi.org/10.1016/j.hrtlng.2021.02.003

Montone RA, Camilli M, Calvieri C, Magnani G, Bonanni A, Bhatt DL, et al. Exposome in ischaemic heart disease: Beyond traditional risk factors. Eur Heart J. 2024;45(6):419–38.

Wenn P, Meshoyrer D, Barber M, Ghaffar A, Razka M, Jose S, et al. Perceived Social Support and its Effects on Treatment Compliance and Quality of Life in Cardiac Patients. J Patient Exp. 2022;9:1–7.

McCurley JL, Penedo F, Roesch SC, Isasi CR, Carnethon M, Sotres-Alvarez D, et al. Psychosocial Factors in the Relationship between Socioeconomic Status and Cardiometabolic Risk: the HCHS/SOL Sociocultural Ancillary Study. Ann Behav Med. 2017;51(4):477–88.

Mesa-Vieira C, Grolimund J, von Känel R, Franco OH, Saner H. Psychosocial risk factors in cardiac rehabilitation: Time to screen beyond anxiety and depression. Glob Heart. 2021;16(1):1–12.

McEvoy JW, Jennings C, Kotseva K, De Bacquer D, De Backer G, Erlund I, et al. Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study. Eur Heart J [Internet]. 2024;00(0):1–13. Available from: https://doi.org/10.1093/eurheartj/ehae558

Cesare MD, Bixby H, Gaziano T, Hadeed L, Kabudula C, McGhie D V., et al. World Heart Report 2023: Confronting the World’s Number One Killer. World Hear Fed [Internet]. 2023;1–52. Available from: https://world-heart-federation.org/wp-content/uploads/World-Heart-Report-2023.pdf

Basith S, Manavalan B, Shin TH, Park CB, Lee WS, Kim J, et al. The Impact of Fine Particulate Matter 2.5 on the Cardiovascular System: A Review of the Invisible Killer. Nanomaterials. 2022;12(15).

Tabaghi S, Sheibani M, Khaheshi I, Miri R, Haji Aghajani M, Safi M, et al. Associations between short-term exposure to fine particulate matter and acute myocardial infarction: A case-crossover study. Clin Cardiol. 2023;(July):1319–25.

Desperak P, Desperak A, Szyguła-Jurkiewicz B, Rozentryt P, Lekston A, Gąsior M. The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention. J Clin Med. 2022;11(3).

Gavriilaki E, Anyfanti P, Gavriilaki M, Lazaridis A, Douma S, Gkaliagkousi E. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Curr Hypertens Rep [Internet]. 2020 Sep 1 [cited 2021 Nov 17];22(9):1–12. Available from: https://link.springer.com/article/10.1007/s11906-020-01078-6

Kumar A, Ansari MR, Mustafa C, Ansari R. Endothelial dysfunction complications and current status. Pharma Innov J [Internet]. 2019;8(9):25–33. Available from: www.thepharmajournal.com

Auer J, Lamm G. Flexible addition of risk modifiers on top of SCORE2 to improve long-term risk prediction in healthy individuals. Vol. 30, European Journal of Preventive Cardiology. Oxford University Press US; 2023. p. 1702–4.

Sigurdardottir FD, Lyngbakken MN, Holmen OL, Dalen H, Hveem K, Røsjø H, et al. Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study). Am J Cardiol [Internet]. 2018;121(8):949–55. Available from: https://www.sciencedirect.com/science/article/pii/S0002914918300973

Haq A, Veerati T, Walser-Kuntz E, Aldujeli A, Tang M, Miedema M. Coronary artery calcium and the risk of cardiovascular events and mortality in younger adults: a meta-analysis. Eur J Prev Cardiol [Internet]. 2024;31(9):1061–9. Available from: https://doi.org/10.1093/eurjpc/zwad399




DOI: https://doi.org/10.21776/ub.hsj.2024.005.04.1

DOI (PDF): https://doi.org/10.21776/ub.hsj.2024.005.04.1

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Ade Meidian Ambari

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.